Challenges in the research and development of new human vaccines
Autor(a) principal: | |
---|---|
Data de Publicação: | 2013 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/7261 |
Resumo: | Fundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Salvador, BA, Brasil |
id |
CRUZ_05285cb71ccb30c5e5d67f597d7b2db7 |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/7261 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Bessa, Theolis Costa BarbosaBarral Netto, Manoel2013-11-25T19:29:46Z2013-11-25T19:29:46Z2013BARBOSA, T.; BARBOSA, T. Challenges in the research and development of new human vaccines. Brazilian Journal of Medical and Biological Research, v. 46, n. 2, p.103-108, 2013.1414-431Xhttps://www.arca.fiocruz.br/handle/icict/726110.1590/1414-431X20131873engFaculdade de Medicina de Ribeirao PretoChallenges in the research and development of new human vaccinesinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleFundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Salvador, BA, BrasilFundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Salvador, BA, BrasilThe field of vaccinology was born from the observations by the fathers of vaccination, Edward Jenner and Louis Pasteur, that a permanent, positive change in the way our bodies respond to life-threatening infectious diseases can be obtained by specific challenge with the inactivated infectious agent performed in a controlled manner, avoiding the development of clinical disease upon exposure to the virulent pathogen. Many of the vaccines still in use today were developed on an empirical basis, essentially following the paradigm established by Pasteur, ‘‘isolate, inactivate, and inject’’ the disease-causing microorganism, and are capable of eliciting uniform, long-term immune memory responses that constitute the key to their proven efficacy. However, vaccines for pathogens considered as priority targets of public health concern are still lacking. The literature tends to focus more often on vaccine research problems associated with specific pathogens, but it is increasingly clear that there are common bottlenecks in vaccine research, which need to be solved in order to advance the development of the field as a whole. As part of a group of articles, the objective of the present report is to pinpoint these bottlenecks, exploring the literature for common problems and solutions in vaccine research applied to different situations. Our goal is to stimulate brainstorming among specialists of different fields related to vaccine research and development. Here, we briefly summarize the topics we intend to deal with in this discussion.Human vaccinesVaccine issuesVaccine efficacyImmunization strategiesinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZORIGINALBarbosa T Challenges in the....pdfBarbosa T Challenges in the....pdfapplication/pdf210220https://www.arca.fiocruz.br/bitstream/icict/7261/1/Barbosa%20T%20Challenges%20in%20the....pdfa3500b1dd61d3123c0b596b7594c3fdbMD51LICENSElicense.txtlicense.txttext/plain; charset=utf-81914https://www.arca.fiocruz.br/bitstream/icict/7261/2/license.txt7d48279ffeed55da8dfe2f8e81f3b81fMD52TEXTBarbosa T Challenges in the....pdf.txtBarbosa T Challenges in the....pdf.txtExtracted texttext/plain31917https://www.arca.fiocruz.br/bitstream/icict/7261/5/Barbosa%20T%20Challenges%20in%20the....pdf.txtc291243be41e6e465e02a6038792de56MD55THUMBNAILBarbosa T Challenges in the....pdf.jpgBarbosa T Challenges in the....pdf.jpgGenerated Thumbnailimage/jpeg2156https://www.arca.fiocruz.br/bitstream/icict/7261/4/Barbosa%20T%20Challenges%20in%20the....pdf.jpg97a1fd65137db737f35319e554a9898bMD54icict/72612023-03-15 14:32:53.857oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-03-15T17:32:53Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.pt_BR.fl_str_mv |
Challenges in the research and development of new human vaccines |
title |
Challenges in the research and development of new human vaccines |
spellingShingle |
Challenges in the research and development of new human vaccines Bessa, Theolis Costa Barbosa Human vaccines Vaccine issues Vaccine efficacy Immunization strategies |
title_short |
Challenges in the research and development of new human vaccines |
title_full |
Challenges in the research and development of new human vaccines |
title_fullStr |
Challenges in the research and development of new human vaccines |
title_full_unstemmed |
Challenges in the research and development of new human vaccines |
title_sort |
Challenges in the research and development of new human vaccines |
author |
Bessa, Theolis Costa Barbosa |
author_facet |
Bessa, Theolis Costa Barbosa Barral Netto, Manoel |
author_role |
author |
author2 |
Barral Netto, Manoel |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Bessa, Theolis Costa Barbosa Barral Netto, Manoel |
dc.subject.en.pt_BR.fl_str_mv |
Human vaccines Vaccine issues Vaccine efficacy Immunization strategies |
topic |
Human vaccines Vaccine issues Vaccine efficacy Immunization strategies |
description |
Fundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Salvador, BA, Brasil |
publishDate |
2013 |
dc.date.accessioned.fl_str_mv |
2013-11-25T19:29:46Z |
dc.date.available.fl_str_mv |
2013-11-25T19:29:46Z |
dc.date.issued.fl_str_mv |
2013 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
BARBOSA, T.; BARBOSA, T. Challenges in the research and development of new human vaccines. Brazilian Journal of Medical and Biological Research, v. 46, n. 2, p.103-108, 2013. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/7261 |
dc.identifier.issn.none.fl_str_mv |
1414-431X |
dc.identifier.doi.none.fl_str_mv |
10.1590/1414-431X20131873 |
identifier_str_mv |
BARBOSA, T.; BARBOSA, T. Challenges in the research and development of new human vaccines. Brazilian Journal of Medical and Biological Research, v. 46, n. 2, p.103-108, 2013. 1414-431X 10.1590/1414-431X20131873 |
url |
https://www.arca.fiocruz.br/handle/icict/7261 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Faculdade de Medicina de Ribeirao Preto |
publisher.none.fl_str_mv |
Faculdade de Medicina de Ribeirao Preto |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/7261/1/Barbosa%20T%20Challenges%20in%20the....pdf https://www.arca.fiocruz.br/bitstream/icict/7261/2/license.txt https://www.arca.fiocruz.br/bitstream/icict/7261/5/Barbosa%20T%20Challenges%20in%20the....pdf.txt https://www.arca.fiocruz.br/bitstream/icict/7261/4/Barbosa%20T%20Challenges%20in%20the....pdf.jpg |
bitstream.checksum.fl_str_mv |
a3500b1dd61d3123c0b596b7594c3fdb 7d48279ffeed55da8dfe2f8e81f3b81f c291243be41e6e465e02a6038792de56 97a1fd65137db737f35319e554a9898b |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1813009237589098496 |